402 filings
Page 5 of 21
6-K
9zt3u7jr7z6vj
19 Jan 22
Jyseleca®▼ (Filgotinib) Licensed for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis In Great Britain
11:37am
6-K
7z7rfa
13 Jan 22
Galapagos creates new subscription right plan
4:32pm
6-K
ayp0m4
10 Jan 22
Galapagos to present at 40th Annual J.P. Morgan Healthcare Conference
3:12pm
6-K
0xize
6 Dec 21
Current report (foreign)
6:00am
6-K
y5cbn5bw0k63h6r4wlj
29 Nov 21
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
6:00am
6-K
epixx1w2bkmoy8u
17 Nov 21
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
6:00am
6-K
uwdfb5buqfc8a
8 Nov 21
Galapagos reports commercial and operational progress at Q3 financial results
4:03pm
S-8
gk9kg
26 Oct 21
Registration of securities for employees
4:07pm
6-K
2n43q9 d86
6 Oct 21
Galapagos presents new data from the SELECTION Phase 3 program at the United European Gastroenterology Week (UEGW) 2021 congress
6:00am
6-K
4arrdig
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
2jg9j v282smv
21 Sep 21
Current report (foreign)
12:00am
6-K
hku9gimym8k3 on
20 Sep 21
Current report (foreign)
9:26am
6-K
a7ap38jniv9th0sbn8
31 Aug 21
Galapagos announces planned retirement of CEO
3:46pm
6-K
c03qr
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
3cv0ltdzryg9p6g7hh
14 Jul 21
Current report (foreign)
5:27pm
6-K
k89yhv mox
14 Jul 21
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
5:13pm
6-K
lfdak rfoi7ah
12 Jul 21
New post-hoc analyses of data from SELECTION Phase 3 program presented at European Crohn’s and Colitis Organisation (ECCO) virtual congress
9:02am
6-K
bziclz0u
23 Jun 21
Galapagos announces departure of CSO Piet Wigerinck later this year
6:00am
6-K
rsrrnpvbvgai
8 Jun 21
Current report (foreign)
6:14am
6-K
y1zpox8x6v
4 Jun 21
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
6:05am